What is Purple Biotech (PPBT) stock price today?

Purple Biotech (PPBT) currently trades at $4.23 per share. The stock has a market capitalization of $6.95M and a P/E ratio of —x.

Is PPBT stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Purple Biotech has a Smart Value Score of 26/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 2/9 and Altman Z-Score is -1.15.

Is Purple Biotech financially healthy?

Purple Biotech's Piotroski F-Score is 2/9 (weak financial health). The Altman Z-Score of -1.15 places it in the distress.

PPBT

Purple Biotech

NASDAQ: PPBT · HEALTHCARE · BIOTECHNOLOGY

$4.23

-6.90% today

Updated 2026-04-29

Market cap

$6.95M

P/E ratio

—

P/S ratio

58.08x

EPS (TTM)

$-54.00

Dividend yield

—

52W range

$4 – $29

Volume

0.0M

Market cap

$6.95M

P/E ratio

—

P/S ratio

58.08x

EPS (TTM)

$-54.00

Dividend yield

—

52W range

$4 – $29

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.5

Quality

C+

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

-1.2

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$30.00

+609.22%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.01x — low leverage

Risks

- Piotroski 2/9 — weak financial health

- Altman Z -1.15 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-2.08M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$-910000.00	$195804.00	$0.00	$0.00	$0.00
Net income	$-21.67M	$-19880.00	$-7.24M	$-26.81M	$-23.89M
EPS	—	—	—	—	$-54.00
Free cash flow	$-16.96M	$-19.93M	$-14.37M	$-5.54M	$-2.08M
Profit margin	2,381.10%	-10.15%	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
PPBT	$6.95M	26	4.3	3.0	5.0	5.5	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Purple Biotech trades at $4.23. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -1.15, it sits in the distress.

Frequently asked questions

What is Purple Biotech's stock price?

Purple Biotech (PPBT) trades at $4.23.

Is Purple Biotech overvalued?

Smart Value Score 26/100 (Grade F, Strong Sell).

What is the price target of Purple Biotech (PPBT)?

The analyst target price is $30.00, representing +609.2% upside from the current price of $4.23.

Piotroski F-Score?

2/9 — weak financial health.

Altman Z-Score?

-1.15 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio58.08x

ROE-124.50%

Beta-0.70

50D MA$4.43

200D MA$9.14

Shares out0.00B

Float1.84B

Short ratio—

Avg volume0.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

PPBT vs LLY →PPBT vs JNJ →PPBT vs ABBV →Stock screener →